The abstract is read at the publisher; the summary is JClub's.
Aspirin alone after total hip or knee arthroplasty is noninferior to rivaroxaban followed by aspirin for symptomatic venous thromboembolism, with rates of 0.48% vs 0.45%.
- Why it matters: Uncertainty remained about whether aspirin alone could match the safety and effectiveness of an initial short course of rivaroxaban after arthroplasty.
- What they did: In a multicenter, double-blind randomized trial of 5429 patients, participants received 81 mg aspirin or 10 mg rivaroxaban daily for 5 days, then 81 mg aspirin daily for 9 days after knee or 30 days after hip, followed for 90 days.
- The result: Symptomatic venous thromboembolism occurred in 13/2718 vs 12/2647 (risk difference 0.02 percentage points; 95% CI -0.34 to 0.39; P<0.001 for noninferiority), and major or clinically relevant nonmajor bleeding was 1.66% vs 2.04% without a clinically relevant difference.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.